Highly active antiretroviral therapy (HAART) has become so efficient that it leaves HIV-infected people with undetectable viral loads, allowing them to lead almost normal lives. Their lifespan, however, is still about ten years shorter than that of uninfected people. One major reason for this is that they suffer from chronic inflammation, much of it due to poor gut health, which can result in the translocation of bacteria into the blood.
Blog
News
- 59 posts in this category
News from the frontlines of the US AIDS epidemic, now more than three decades old, paints a mixed picture of national efforts to combat HIV transmission.
The good news: The number of new HIV infections among black females ages 13 and older declined 21% from 2008 to 2010.
The good news: The number of new HIV infections among black females ages 13 and older declined 21% from 2008 to 2010.
The bad: New HIV infections among gay and bisexual males ages 13-24 rose by 22% over the same period (see chart).
Our latest edition spotlights the work of labs owned by Product Development Partnerships, the science behind particle-based recombinant vaccines and recent strides in AIDS vaccine research using humanized mouse models. Enjoy!
It’s been about a year since US Secretary of State Hillary Clinton, whose department oversees the President’s Emergency Plan for AIDS Relief (PEPFAR), set a goal of achieving an AIDS-free generation (see VAX Global News,With HIV Incidence Plateauing, a Push for an AIDS-Free Society, Nov. 2011).
Hurricane Sandy got in the way! IAVI's offices in lower Manhattan were flooded during the horrific October storm--just as IAVI Report was going to press--so it took us a bit longer to get out the door. But we're finally here! Our latest edition of IAVI Report covers a brewing debate over how soon HIV-infected people should be offered treatment, highlights from the 2012 AIDS Vaccine meeting in Boston and a Q&A with US Military HIV Research Director Nelson Michael.